Compare CNO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNO | LGND |
|---|---|---|
| Founded | 1979 | 1987 |
| Country | United States | United States |
| Employees | 3300 | 68 |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | N/A | N/A |
| Metric | CNO | LGND |
|---|---|---|
| Price | $50.32 | $253.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $46.50 | ★ $256.29 |
| AVG Volume (30 Days) | ★ 606.3K | 159.7K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.25 |
| Revenue Next Year | $3.42 | $19.41 |
| P/E Ratio | ★ $18.71 | $76.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.24 | $111.72 |
| 52 Week High | $50.20 | $258.57 |
| Indicator | CNO | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 75.48 | 72.06 |
| Support Level | $38.95 | $199.97 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.77 | 7.35 |
| MACD | 0.26 | 2.29 |
| Stochastic Oscillator | 91.65 | 86.05 |
CNO Financial Group Inc is a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.